NO2930176T3 - - Google Patents
Info
- Publication number
- NO2930176T3 NO2930176T3 NO13862318A NO13862318A NO2930176T3 NO 2930176 T3 NO2930176 T3 NO 2930176T3 NO 13862318 A NO13862318 A NO 13862318A NO 13862318 A NO13862318 A NO 13862318A NO 2930176 T3 NO2930176 T3 NO 2930176T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012269178 | 2012-12-10 | ||
PCT/JP2013/083022 WO2014092061A1 (ja) | 2012-12-10 | 2013-12-10 | ヒダントイン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2930176T3 true NO2930176T3 (tr) | 2018-07-07 |
Family
ID=50934349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO13862318A NO2930176T3 (tr) | 2012-12-10 | 2013-12-10 |
Country Status (35)
Country | Link |
---|---|
US (5) | US9428505B2 (tr) |
EP (1) | EP2930176B1 (tr) |
JP (1) | JP5951799B2 (tr) |
KR (1) | KR102168738B1 (tr) |
CN (1) | CN104854106B (tr) |
AU (1) | AU2013358167B2 (tr) |
BR (1) | BR112015012411B1 (tr) |
CA (1) | CA2892621C (tr) |
CL (2) | CL2015001391A1 (tr) |
CR (1) | CR20150272A (tr) |
DK (1) | DK2930176T3 (tr) |
ES (1) | ES2663797T3 (tr) |
HK (1) | HK1209735A1 (tr) |
HR (1) | HRP20180647T1 (tr) |
HU (1) | HUE037530T2 (tr) |
IL (1) | IL238277B (tr) |
LT (1) | LT2930176T (tr) |
MA (1) | MA38250B1 (tr) |
MX (1) | MX2015007309A (tr) |
MY (1) | MY178583A (tr) |
NO (1) | NO2930176T3 (tr) |
NZ (1) | NZ707946A (tr) |
PE (1) | PE20151295A1 (tr) |
PH (1) | PH12015501146B1 (tr) |
PL (1) | PL2930176T3 (tr) |
PT (1) | PT2930176T (tr) |
RS (1) | RS57190B1 (tr) |
RU (1) | RU2678984C2 (tr) |
SA (1) | SA515360528B1 (tr) |
SG (1) | SG11201504204XA (tr) |
SI (1) | SI2930176T1 (tr) |
TW (1) | TWI615394B (tr) |
UA (1) | UA115072C2 (tr) |
WO (1) | WO2014092061A1 (tr) |
ZA (1) | ZA201503597B (tr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2433940T3 (en) | 2009-04-28 | 2015-01-12 | Chugai Pharmaceutical Co Ltd | Spiroimidazolonderivat |
NO2930176T3 (tr) * | 2012-12-10 | 2018-07-07 | ||
BR112016003511B8 (pt) * | 2014-06-09 | 2023-10-03 | Chugai Pharmaceutical Co Ltd | Composição farmacêutica que contém derivados de hidantoína e uso dos mesmos |
MX2021001063A (es) | 2018-07-30 | 2021-04-12 | Chugai Pharmaceutical Co Ltd | Dispersion solida de derivado de hidantoina. |
CN110464002A (zh) * | 2019-09-12 | 2019-11-19 | 西南石油大学 | 一种天然冰粉的制备方法及其应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1135470A (ja) * | 1997-07-23 | 1999-02-09 | Teijin Ltd | ビタミンd3誘導体を含有する副甲状腺ホルモン産生促進剤 |
TR200101644T2 (tr) | 1998-12-11 | 2001-11-21 | F.Hoffmann-La Roche Ag | TNF-ALFA önleyicileri olarak siklik hidrazin türevleri. |
AU2001284412A1 (en) | 2000-08-30 | 2002-03-13 | Teijin Limited | Parathyroid hormone production inhibitors containing vitamin D3 derivatives |
EE200300196A (et) * | 2000-10-26 | 2003-10-15 | Pfizer Products Inc. | Spiropürimidiin-2,4,6-trioonmetalloproteinaasi inhibiitorid |
SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
AR038658A1 (es) | 2001-06-15 | 2005-01-26 | Novartis Ag | Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento |
EP1514246A4 (en) * | 2002-06-06 | 2008-04-16 | Donnelly Corp | COMPASS INTERIOR COURTESY MIRROR SYSTEM |
EP1713815A4 (en) * | 2004-02-11 | 2009-03-11 | Smithkline Beecham Corp | PTH AGONISTS |
JP2007522215A (ja) * | 2004-02-11 | 2007-08-09 | スミスクライン・ビーチャム・コーポレイション | Pthアゴニスト |
EP1799672B1 (en) | 2004-10-07 | 2013-01-02 | Merck Sharp & Dohme Corp. | Cgrp receptor antagonists |
WO2007135417A1 (en) | 2006-05-19 | 2007-11-29 | James Black Foundation | Benzotriazepinone derivatives |
CN101472924A (zh) | 2006-06-20 | 2009-07-01 | 惠氏公司 | Kv1.5钾通道抑制剂 |
ATE486058T1 (de) | 2007-06-07 | 2010-11-15 | Hoffmann La Roche | Prolinamidderivate als nk3-antagonisten |
TWI439462B (zh) | 2007-12-10 | 2014-06-01 | Novartis Ag | 作為enac阻抑劑之螺環胍化合物 |
US7981904B2 (en) | 2008-03-20 | 2011-07-19 | Takeda Pharmaceutical Company Limited | Acetyl CoA carboxylase inhibitors |
WO2010045229A2 (en) | 2008-10-13 | 2010-04-22 | University Of Rochester | Protecting and repairing cartilage and musculoskeletal soft tissues |
DK2433940T3 (en) * | 2009-04-28 | 2015-01-12 | Chugai Pharmaceutical Co Ltd | Spiroimidazolonderivat |
NO2930176T3 (tr) * | 2012-12-10 | 2018-07-07 | ||
BR112016003511B8 (pt) * | 2014-06-09 | 2023-10-03 | Chugai Pharmaceutical Co Ltd | Composição farmacêutica que contém derivados de hidantoína e uso dos mesmos |
-
2013
- 2013-12-10 NO NO13862318A patent/NO2930176T3/no unknown
- 2013-12-10 EP EP13862318.6A patent/EP2930176B1/en active Active
- 2013-12-10 KR KR1020157017844A patent/KR102168738B1/ko active IP Right Grant
- 2013-12-10 UA UAA201504548A patent/UA115072C2/uk unknown
- 2013-12-10 MX MX2015007309A patent/MX2015007309A/es active IP Right Grant
- 2013-12-10 PL PL13862318T patent/PL2930176T3/pl unknown
- 2013-12-10 CA CA2892621A patent/CA2892621C/en active Active
- 2013-12-10 WO PCT/JP2013/083022 patent/WO2014092061A1/ja active Application Filing
- 2013-12-10 SG SG11201504204XA patent/SG11201504204XA/en unknown
- 2013-12-10 MA MA38250A patent/MA38250B1/fr unknown
- 2013-12-10 CN CN201380064459.1A patent/CN104854106B/zh active Active
- 2013-12-10 LT LTEP13862318.6T patent/LT2930176T/lt unknown
- 2013-12-10 DK DK13862318.6T patent/DK2930176T3/en active
- 2013-12-10 PE PE2015000878A patent/PE20151295A1/es active IP Right Grant
- 2013-12-10 RS RS20180517A patent/RS57190B1/sr unknown
- 2013-12-10 BR BR112015012411-9A patent/BR112015012411B1/pt active IP Right Grant
- 2013-12-10 MY MYPI2015701868A patent/MY178583A/en unknown
- 2013-12-10 TW TW102145318A patent/TWI615394B/zh active
- 2013-12-10 AU AU2013358167A patent/AU2013358167B2/en active Active
- 2013-12-10 NZ NZ70794613A patent/NZ707946A/en unknown
- 2013-12-10 ES ES13862318.6T patent/ES2663797T3/es active Active
- 2013-12-10 PT PT138623186T patent/PT2930176T/pt unknown
- 2013-12-10 SI SI201331009T patent/SI2930176T1/en unknown
- 2013-12-10 JP JP2014552040A patent/JP5951799B2/ja active Active
- 2013-12-10 HU HUE13862318A patent/HUE037530T2/hu unknown
- 2013-12-10 US US14/426,408 patent/US9428505B2/en active Active
- 2013-12-10 RU RU2015127624A patent/RU2678984C2/ru active
-
2015
- 2015-04-14 IL IL238277A patent/IL238277B/en active IP Right Grant
- 2015-05-21 ZA ZA2015/03597A patent/ZA201503597B/en unknown
- 2015-05-21 CR CR20150272A patent/CR20150272A/es unknown
- 2015-05-22 CL CL2015001391A patent/CL2015001391A1/es unknown
- 2015-05-22 PH PH12015501146A patent/PH12015501146B1/en unknown
- 2015-06-04 SA SA515360528A patent/SA515360528B1/ar unknown
- 2015-10-23 HK HK15110436.4A patent/HK1209735A1/xx unknown
-
2016
- 2016-07-20 US US15/214,729 patent/US20160326175A1/en not_active Abandoned
-
2017
- 2017-01-11 CL CL2017000069A patent/CL2017000069A1/es unknown
- 2017-12-20 US US15/848,267 patent/US20180237436A1/en not_active Abandoned
-
2018
- 2018-04-24 HR HRP20180647TT patent/HRP20180647T1/hr unknown
-
2020
- 2020-02-28 US US16/805,204 patent/US20210024524A1/en not_active Abandoned
-
2021
- 2021-05-25 US US17/330,200 patent/US20220162208A1/en active Pending